drugset / Trial / NCT01120496

Nebulized Hypertonic Saline Treatment in Hospitalized Children With Moderate to Severe Viral Bronchiolitis

NCT01120496 ↗

Completed 135 enrolled Chongqing Medical University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is planned to investigate whether frequently inhaled hypertonic saline (HS) can relieve symptoms and signs faster than normal saline (NS) and shorten length of stay (LOS) significantly for moderately to severely ill infants with bronchiolitis without apparent adverse effects.

Timeline

Start
2008-11
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject 3% hypertonic saline Unknown 3 % Inhaled
Subject 3% hypertonic saline Unknown 4 ml Inhaled

Indications